Harrow Health, Inc to Locate Headquarters in Nashville, Tennessee
18 juin 2019 10h51 HE
|
Harrow Health, Inc.
NASHVILLE, Tenn., June 18, 2019 (GLOBE NEWSWIRE) -- Tennessee Governor, Bill Lee, Department of Economic and Community Development Commissioner Bob Rolfe and Harrow Health, Inc (NASDAQ: HROW)...
Harrow Health Announces Renegotiated Debt Facility with SWK Holdings
29 mai 2019 07h00 HE
|
Harrow Health, Inc.
SAN DIEGO, May 29, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced it has amended its loan agreement with SWK Funding LLC and its partners. SWK Funding LLC is a...
Harrow Health Announces First Quarter 2019 Financial Results
09 mai 2019 16h01 HE
|
Harrow Health, Inc.
SAN DIEGO, May 09, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the first quarter 2019. First Quarter 2019 and Other Recent Notable Highlights: ...
Harrow Health to Present at the 20th Annual B. Riley FBR Institutional Investor Conference on May 22, 2019
07 mai 2019 07h00 HE
|
Harrow Health, Inc.
SAN DIEGO, May 07, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that its Chief Executive Officer, Mark L. Baum, will present an update on the company’s business at the...
Harrow Health to Announce First Quarter 2019 Financial Results on May 9, 2019
02 mai 2019 07h00 HE
|
Harrow Health, Inc.
SAN DIEGO, May 02, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced it will release first quarter 2019 financial results after the close of trading on Thursday, May 9,...
ImprimisRx to Introduce New Formulations at Cataract & Refractive Surgery Annual Meeting
30 avr. 2019 07h00 HE
|
Harrow Health, Inc.
SAN DIEGO, April 30, 2019 (GLOBE NEWSWIRE) -- ImprimisRx, the ophthalmology-focused pharmaceutical compounding subsidiary of Harrow Health, Inc. (NASDAQ: HROW), today announced its participation at...
Harrow Health Announces Fourth Quarter 2018 Financial Results
12 mars 2019 16h01 HE
|
Harrow Health, Inc.
SAN DIEGO, March 12, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the fourth quarter 2018. Fourth Quarter 2018 and Other Recent Notable Highlights: ...
Harrow Health to Attend 31st Annual ROTH Conference on March 18, 2019
04 mars 2019 07h00 HE
|
Harrow Health, Inc.
SAN DIEGO, March 04, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that it will be attending the 31st Annual ROTH Conference March 18-19, 2019 at The Ritz Carlton,...
Harrow Health to Announce Fourth Quarter 2018 Financial Results on March 12, 2019
28 févr. 2019 07h00 HE
|
Harrow Health, Inc.
SAN DIEGO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced it will release fourth quarter 2018 financial results after the close of trading on Tuesday, March 12,...
Melt Pharmaceuticals Improves Patent Estate for Sublingual Non-Opioid Pain and Sedation Formulations
13 févr. 2019 07h00 HE
|
Harrow Health, Inc.; Melt Pharmaceuticals
SAN DIEGO and BOSTON, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Melt Pharmaceuticals, Inc., a specialty pharmaceutical company recently deconsolidated from Harrow Health, Inc. (NASDAQ: HROW), today...